1 / 36

The Arizona Prescription Drug Misuse and Abuse Initiative

The Arizona Prescription Drug Misuse and Abuse Initiative. A Multi-Systemic Approach for Targeting Rx Drug Misuse and Abuse. The “Silent” Epidemic. In November 2011, the CDC reported that deaths from Rx Pain Relievers have reached epidemic proportions

eitan
Download Presentation

The Arizona Prescription Drug Misuse and Abuse Initiative

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Arizona Prescription Drug Misuse and Abuse Initiative A Multi-Systemic Approach for Targeting Rx Drug Misuse and Abuse

  2. The “Silent” Epidemic • In November 2011, the CDC reported that deaths from Rx Pain Relievers have reached epidemic proportions • Rx Pain Reliever deaths are greater than heroin and cocaine combined • Drug poisoning deaths have surpassed motor vehicle deaths • ~40 deaths per day and ~15,000 per year (2008) – a 3 fold increase since 1999 • Half a million ED visits per year for misuse and abuse (2009) • There was a 4 fold increase in the quantity of Rx Pain Relievers sold in the U.S. in the last decade • Enough Rx Pain Relievers were prescribed in 2012 to medicate every Arizona adult around-the-clock for more than two weeks. • In some areas of Arizona, this is as high as 4 weeks

  3. The Problem? ~ 585 million Class II-IV pills were prescribed in Arizona in 2012 Pain Relievers had the highest % of scripts, pills and average number of pills per day; accounting for 58.5% of all pills prescribed Hydrocodoneand Oxycodoneaccounted for 82.4% of all pain relievers prescribed in Arizona Why it matters = probability and access!

  4. Who Is It Affecting? ARIZONA ADULTS In 2010, ~50% of adults reported Rx drug misuse in the past 12 months and 13%reported misuse in the past 30 days • 47% of Rx abusers reported misusing Pain Relievers, 32% Sedatives and 3.3% Stimulants

  5. Who Is It Affecting? ARIZONA YOUTH • In 2012, 7.9% of AZ youth reported current Rx drug misuse (the most commonly used substance after alcohol, tobacco and marijuana) • Though a moderate decrease occurred between 2010 and 2012, Arizona remains the 6th highest state in the country for Rx drug misuse among individuals 12+ years • While rates of Rx type use were comparable to national levels for Sedatives and Stimulants, Arizona youth in all grades reported higher rates ofPain Reliever misuse • Themajority of youth (92.7%) reportedobtaining them from everyday sources (e.g. friends and family/home)

  6. What Is It Costing Us? • Mortality & Morbidity • Opioid-related cases in theEDhave consistentlyincreased • An 86% increase between 2008-2011 • 490 deaths involved Rx narcotic drugs in AZ in 2010 (A 53.5% increase between ‘06-’10) • 11% were youth & young adults ages of 15-24 years • Opioid Analgesics accounted for 64.3% • Health insurance and AHCCCS costs • 45.9% of opioid-related AZ ED cases in 2011 werepaid for by AHCCCS/Medicaid • CDC estimates Rx Pain Relievers cost health insurers up to $72.5 billion annually • Increase in Crime • Increase in DUI-D • Increase in babies born with NAS

  7. What Is Amplifying The Problem?i.e., What Can We Change? • Social acceptance and the perception of “safety” by parents, youth, health consumers and some medical professionals • Lack of proper disposal and storage • Lack of understanding about risks • Lack of resilience skills • Only 23% of AZ prescribers are using the Prescription Drug Monitoring Program (PDMP) • Imbalanced dose: diagnosis correspondence (e.g., 60 count Oxycodone 30mg for wisdom teeth removal) • Lack ofeducation and inconsistent prescribing guidelines forRx narcotics – prescribers were told a little over a decade ago that they weren’t assessing pain well enough • Unrealistic expectations of the Health Consumer for zero pain and immediate gratification

  8. FINDING A SOLUTION A Multi-Systemic Approach: Law Enforcement, Medical/Treatment, and Prevention

  9. History and Foundation • Early in 2011, ONDCP published the Rx Drug Abuse prevention plan • AZ HIDTA took the lead and held a Rx Drug Summit in October, 2011 • Focus was in 3 domains: law enforcement, medical/treatment, prevention • Following the ONDCP recommendations, the summit sessions lead to recommendations for education, tracking and monitoring (PDMP), proper Rx disposal and law enforcement initiatives • The Arizona Substance Abuse Partnership (ASAP) made Rx drug abuse their strategic area of focus in January 2012

  10. The Rx Drug Misuse and Abuse Initiative • Using the ONDCP and the AZ Rx Summit recommendations, ACJC and GOCYF hosted a Rx Drug Expert Panel in February, 2012 • The panel and attendees involved local stakeholders from law enforcement, medical/treatment, and prevention/education • A set of strategies was developed from recommendations made by the expert panel and attendees and three pilot counties were chosen for a pilot project implementation • The pilot project will serve as a feasibility study to demonstrate the feasibility and efficacy (where measurable) of the strategies for an eventual statewide initiative

  11. Selection of the Pilot Counties • 3 pilot counties (Yavapai, Pinal and Graham/Greenlee) were chosen based on the following criteria: • Evidence of severe Rx drug problem among youth and adults demonstrated across multiple data sources • Willingness to use data-driven-decision-making to target and tailor implementation to specific geographic areas and demographic populations within the county • Capacity for implementation: coalitions and working groups consisting of members from the 3 domains of law enforcement, medical/tx, prevention

  12. Initiative Core and • Arizona Substance Abuse Partnership • Leveraging existing resources • Data-driven-decision-making • Expert Panel and Sector Champions • Public Health vs. Public Safety: a multi-systemic approach • Coalitions, Task Groups and Local Champions • The vehicles of change • “Our Own Backyard” approach

  13. The Strategies ReduceIllicit Acquisition and Diversion of Rx Drugs Promote Responsible Prescribing and Dispensing Policies and Practices Enhance Rx Drug Practice and Policies in Law Enforcement Increase Public Awareness and Patient Education about Rx Drug Misuse Enhance Assessment and Referral to Treatment

  14. Conceptual FrameworkExpected Increases(+)and Decreases(-) SUPPLY + + - Health ED visits Deaths NAS Tx Admissions - - - Availability Misuse and Abuse Consequences - Crime & Delinquency School Suspensions Drunk/High @ School Youth Arrests Rx Drug Investigations DUI-D Lack of LE Training DEMAND - - Unsafe Storage & Disposal Sharing Scripts Lack of Resistance Strategies Lack of Parent-Child Communication Social Acceptance Perceived Low Risk Expectations of Health Consumer

  15. Strategy #1: Reduce Acquisition • ProperDisposal • Permanent drop boxes • Take-back events • Community education and awareness • Proper Storage • Community education and awareness • Increase the use of the PDMP • More law enforcement, prescribers and dispensers signed up and using the PDMP • A data feedback system for prescribers to self-monitor prescribing practices – the prescriber report card

  16. PMDP Prescriber Report Card

  17. Strategy #2: Promote Responsible Prescribing • Develop and Implement research-based “Best Practice” Guidelinesfor prescribers and pharmacists • Prescribing and dispensing guidelines identifying when, where, and how much to prescribe; standards for refills; pain management contracts; wean-off plans; prescriber – pharmacist communication protocols • Patient education that helps prescribers and pharmacists improve the prescription drug literacy of their patients (e.g., side effects, risks, alternatives, adherence to treatment, proper storage and disposal, realistic pain management expectations, etc.) • A self-monitoring system (i.e., report cards) for prescribers to identify their prescribing habits relative to other prescribers of their specialty type

  18. Strategy #3: Enhance Rx Drug Practice and Policies in Law Enforcement • Education and training for law enforcement officers • Prevalence of Rx drug abuse and diversion crimes • Pill recognition, use of poison control, how to read scripts and bottles, Rx street sales/trafficking and related crime • Improve coding structure of data management systems for tracking Rx drug offenses • Add a code to arrest information that flags an Rx drug-related crime

  19. Strategy #4: Increase Public Awareness and Patient Education about Rx Drug Misuse Mass media blasts to create a sense of urgency about the Rx drug misuse and abuse problem in Arizona Rx 360 Youth and Adult curriculums to educate youth, parents and other adults about the risks of Rx drug misuse and the importance of resiliencestrategies Public messaging about risks/benefits, pain management expectations, available alternatives, adherence to Tx

  20. Strategy #5: Enhance Assessment and Referral to Treatment • Prescriber education and training for substance abuse screening and brief intervention • Compilation and distribution of community-specific treatment resources • Decision-trees for when and where to refer patients to substance abuse treatment • Network inventory for public and private options for substance abuse treatment

  21. Evaluating the Impact of our Efforts • Feasibility Study / Pilot Project • Telling the story of the implementation • Learning communities • Measuring Efficacy • Process Evaluation • Monitoring depth and breadth of reach and saturation • Impact Evaluation • Changing knowledge, attitudes, awareness and beliefs • Changing behavior • Outcome Evaluation • Decreasing Misuse and Abuse • Decreasing Health Consequences • Decreasing Criminal Justice Consequences

  22. Strategies

  23. Impact Evaluation

  24. Outcome Evaluation

  25. Process Evaluation HighlightsAs of September 1, 2013 34 drop boxes are operational in the pilots and two take-back events were held in each site, collecting 5,783 lbs 5 of 6 hospitals are implementing ED Guidelines Over 1,100prescribers are receiving quarterly report cards 135 professionals have received comprehensive Best Practice training or door-to-door 201 Law Enforcement Officers have received Rx Crimes curriculum 8,137 youth and 834 adults have received the Rx360 curriculum 17,834 people have been reached via community events Over 397,000 people have been reached via public messaging and media methods

  26. Yavapai County Impact EvaluationRx360 Awareness and Education Curriculum Adults are more aware that Rx drug misuse is a problem Knowledge about the risks of Rx drug misuse increased Knowledge of proper disposal methods increased Adults have recognized the importance of talking to their kids about Rx drug misuse

  27. Yavapai County Impact EvaluationRx Drug Crimes Curriculum Law Enforcement are more aware that Rx drug misuse is a problem in their jurisdictions Law Enforcement have recognized the importance of their role in Rx drug diversion investigations Knowledge of Rx fraud investigation procedures increased

  28. Yavapai County Impact EvaluationPrescription Drug Monitoring Program • PDMP sign up has increased 115% for law enforcement, 53% for prescribers and 149% for pharmacists in the pilot sites • 40% of prescribers are signed up for the PDMP in the pilots vs. 23% at the state • PDMP use has increased 60% for prescribers in Yavapai County • Number of prescribers making the queries increased 14%

  29. Lessons Learned (Already) • PDMP needs improvement • Not real-time • Online sign-up an improvement but mandatory tutorial still cumbersome • Physicians asking for ability to have office designee • Reimbursement/Patient Satisfaction issue • Misconceptions about AHCCCS formulae • Report cards • Category groupings have been challenging, especially in small areas • Need more rigorous method of establishing “outliers” • RMS systems presenting challenges for systematic Rx crimes flagging system • Some improvements needed for the Rx360 curriculum • Resistance strategies component needs adaptation • Need more concrete examples of proper storage methods

  30. Next Steps • Patient Education (e.g., alternatives, adherence to Tx, pain expectations, contracts) • PCP and Community Prescriber Guidelines (ETA: January) • Prescriber Training Modules • Referral to Tx process • Addressing unintended consequences • Pharmacy/Prescriber Communication • Dysphoria and Desperation • Shift to Heroin • Curriculum piece for Pharmacy and Medical student training • Continued endorsement of Boards and Professional Organizations • Legislation – Office Designee; Good Samaritan Law • New Counties and intended statewide plan

  31. Contacts For additional information, please contact: Karen Ziegler (initiative co-chair): kziegler@azcjc.gov Rich Rosky (initiative co-chair): southwest_meth@yahoo.com Tammy Paz-Combs (GOCYF contact): tcombs@az.gov Jeanne Blackburn (state-level strategies; ASAP contact): Jblackburn@az.gov Phil Stevenson (evaluation): pstevenson@azcjc.gov Shana Malone (county-level strategies): smalone@azcjc.gov Dean Wright (PDMP specifics): DWright@azphamcy.gov Tomi St. Mars (prescriber education): Tomi.St.Mars@azdhs.gov

More Related